Intestinal serotonin transporter inhibition by toll-like receptor 2 activation. A feedback modulation

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Latorre, Eva ^a,b   Layunta, Elena ^a,c   Grasa, Laura ^a,c   Castro, Marta ^a,c   Pardo, Julian ^c   Gomollón, Fernando ^d   Alcalde, Ana I ^a,c   Mesonero, José E ^a,c  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SEROTONIN TRANSPORTER; TOLL LIKE RECEPTOR 2; MESSENGER RNA; SEROTONIN; TLR6 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 6;

ANIMAL EXPERIMENT; ARTICLE; CACO-2 CELL LINE; CELL LYSATE; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; INTESTINE; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEROTONINERGIC SYSTEM; SERT GENE; ANIMAL; CYTOLOGY; GENETICS; INTRACELLULAR SPACE; METABOLISM; PHYSIOLOGICAL FEEDBACK; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HUMANS; INTESTINES; INTRACELLULAR SPACE; MICE; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 85007490624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0169303     Document Type: Article

References (52)

1. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010; 10(2): 131-44. Epub 2010/01/26. doi: 10.1038/nri2707 PMID: 20098461
2. Danese S. Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2011; 300(5): G716-22. Epub 2011/01/15. doi: 10.1152/ajpgi.00472.2010 PMID: 21233277
3. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology. 2004; 126(4): 1054-70. Epub 2004/04/02. PMID: 15057745
4. Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis. 2010; 16(9): 1583-97. Epub 2010/08/31. PubMed Central PMCID: PMC2958454. doi: 10.1002/ibd.21282 PMID: 20803699
5. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000; 68(12): 7010-7. Epub 2000/11/18. PubMed Central PMCID: PMC97811. PMID: 11083826
6. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, et al. Toll-like recep-tor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis. 2006; 12(1): 1-8. Epub 2005/12/24. PMID: 16374251
7. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem. 1999; 274(47): 33419-25. Epub 1999/11/24. PMID: 10559223
8. Farhat K, Riekenberg S, Heine H, Debarry J, Lang R, Mages J, et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol. 2008; 83(3): 692-701. Epub 2007/12/07. doi: 10.1189/jlb.0807586 PMID: 18056480
9. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004; 127(1): 224-38. Epub 2004/07/06. PMID: 15236188
10. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 2007; 132(4): 1359-74. Epub 2007/04/06. doi: 10.1053/j.gastro.2007.02.056 PMID: 17408640
11. Hormann N, Brandao I, Jackel S, Ens N, Lillich M, Walter U, et al. Gut microbial colonization orchestrates TLR2 expression, signaling and epithelial proliferation in the small intestinal mucosa. PLoS One. 2014; 9(11): e113080. Epub 2014/11/15. PubMed Central PMCID: PMC4232598. doi: 10.1371/journal.pone.0113080 PMID: 25396415
12. Podolsky DK, Gerken G, Eyking A, Cario E. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology. 2009; 137(1): 209-20. Epub 2009/03/24. PubMed Central PMCID: PMC2812790. doi: 10.1053/j.gastro.2009.03.007 PMID: 19303021
13. Gershon MD Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther. 2004; 20 Suppl 7: 3-14. Epub 2004/11/04.
14. Hansen MB, Witte AB. The role of serotonin in intestinal luminal sensing and secretion. Acta Physiol (Oxf). 2008; 193(4): 311-23. Epub 2008/05/09.
15. Salvador MT, Murillo MD, Rodriguez-Yoldi MC, Alcalde AI, Mesonero JE, Rodriguez-Yoldi MJ. Effects of serotonin on the physiology of the rabbit small intestine. Can J Physiol Pharmacol. 2000; 78(5): 359-66. Epub 2000/06/07. PMID: 10841430
16. Costedio MM, Coates MD, Danielson AB, Buttolph TR 3rd, Blaszyk HJ, Mawe GM, et al. Serotonin signaling in diverticular disease. J Gastrointest Surg. 2008; 12(8): 1439-45. Epub 2008/05/21. PubMed Central PMCID: PMC2910905. doi: 10.1007/s11605-008-0536-5 PMID: 18491196
17. Foley S, Garsed K, Singh G, Duroudier NP, Swan C, Hall IP, et al. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology. 2011; 140(5): 1434-43 e1. Epub 2011/02/15. doi: 10.1053/j.gastro.2011.01.052 PMID: 21315720
18. Mawe GM, Hoffman JM. Serotonin signalling in the gut - functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013; 10(8): 473-86. Epub 2013/06/26. PubMed Central PMCID: PMC4048923. doi: 10.1038/nrgastro.2013.105 PMID: 23797870
19. Bertrand PP, Barajas-Espinosa A, Neshat S, Bertrand RL, Lomax AE. Analysis of real-time serotonin (5-HT) availability during experimental colitis in mouse. Am J Physiol Gastrointest Liver Physiol. 2010; 298(3): G446-55. Epub 2009/12/19. doi: 10.1152/ajpgi.00318.2009 PMID: 20019165
20. Spiller R. Serotonin and GI clinical disorders. Neuropharmacology. 2008; 55(6): 1072-80. Epub 2008/08/09. doi: 10.1016/j.neuropharm.2008.07.016 PMID: 18687345
21. Latorre E, Mendoza C, Matheus N, Castro M, Grasa L, Mesonero JE, et al. IL-10 modulates serotonin transporter activity and molecular expression in intestinal epithelial cells. Cytokine. 2013; 61(3): 778-84. Epub 2013/02/16. doi: 10.1016/j.cyto.2013.01.012 PMID: 23410504
22. Matheus N, Mendoza C, Iceta R, Mesonero JE, Alcalde AI. Regulation of serotonin transporter activity by adenosine in intestinal epithelial cells. Biochem Pharmacol. 2009; 78(9): 1198-204. Epub 2009/06/23. doi: 10.1016/j.bcp.2009.06.006 PMID: 19539610
23. Mendoza C, Matheus N, Iceta R, Mesonero JE, Alcalde AI. Lipopolysaccharide induces alteration of serotonin transporter in human intestinal epithelial cells. Innate Immun. 2009; 15(4): 243-50. Epub 2009/07/10. doi: 10.1177/1753425909104781 PMID: 19587001
24. Mendoza C, Matheus N, Latorre E, Castro M, Mesonero JE, Alcalde AI. Toll-like receptor 3 activation affects serotonin transporter activity and expression in human enterocyte-like Caco-2 cells. Cell Physiol Biochem. 2012; 30(1): 187-98. Epub 2012/07/05. doi: 10.1159/000339057 PMID: 22759966
25. Bogunovic M, Dave SH, Tilstra JS, Chang DT, Harpaz N, Xiong H, et al. Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol. 2007; 292(6): G1770-83. Epub 2007/03/31. PubMed Central PMCID: PMC3203538. doi: 10.1152/ajpgi.00249.2006 PMID: 17395901
26. Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, Zweibaum A, et al. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci. 1994; 107 (Pt 1): 213-25. Epub 1994/01/01.
27. Iceta R, Mesonero JE, Aramayona JJ, Alcalde AI. Molecular characterization and intracellular regulation of the human serotonin transporter in Caco-2 cells. J Physiol Pharmacol. 2006; 57(1): 119-30. Epub 2006/04/08. PMID: 16601320
28. Pardo J, Wallich R, Martin P, Urban C, Rongvaux A, Flavell RA, et al. Granzyme B-induced cell death exerted by ex vivo CTL: discriminating requirements for cell death and some of its signs. Cell Death Differ. 2008; 15(3): 567-79. Epub 2007/12/08. doi: 10.1038/sj.cdd.4402289 PMID: 18064039
29. Iceta R, Aramayona JJ, Mesonero JE, Alcalde AI. Regulation of the human serotonin transporter mediated by long-term action of serotonin in Caco-2 cells. Acta Physiol (Oxf). 2008; 193(1): 57-65. Epub 2007/12/18.
30. Paulino AD, Ubhi K, Rockenstein E, Adame A, Crews L, Letendre S, et al. Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling. J Neurovirol. 2011; 17(4): 327-40. Epub 2011/06/11. doi: 10.1007/s13365-011-0039-0 PMID: 21660601
31. Bertrand PP, Hu X, Mach J, Bertrand RL. Serotonin (5-HT) release and uptake measured by real-time electrochemical techniques in the rat ileum. Am J Physiol Gastrointest Liver Physiol. 2008; 295(6): G1228-36. Epub 2008/10/18. doi: 10.1152/ajpgi.90375.2008 PMID: 18927211
32. O'Hara JR, Ho W, Linden DR, Mawe GM, Sharkey KA. Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am J Physiol Gastrointest Liver Physiol. 2004; 287 (5): G998-1007. Epub 2004/07/03. doi: 10.1152/ajpgi.00090.2004 PMID: 15231483
33. Furrie E, Macfarlane S, Thomson G, Macfarlane GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology. 2005; 115(4): 565-74. Epub 2005/07/14. PubMed Central PMCID: PMC1782176. doi: 10.1111/j.1365-2567.2005.02200.x PMID: 16011525
34. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut micro-biota regulate host serotonin biosynthesis. Cell. 2015; 161(2): 264-76. Epub 2015/04/11. PubMed Central PMCID: PMC4393509. doi: 10.1016/j.cell.2015.02.047 PMID: 25860609
35. Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum. 2010; 62(3): 683-93. Epub 2010/02/05. doi: 10.1002/art.27304 PMID: 20131240
36. Koh SJ, Kim JW, Kim BG, Lee KL, Im JP, Kim JS. Fluoxetine inhibits hyperresponsive lamina propria mononuclear cells and bone marrow-derived dendritic cells, and ameliorates chronic colitis in IL-10-deficient mice. Dig Dis Sci. 2015; 60(1): 101-8. Epub 2014/08/26. doi: 10.1007/s10620-014-3326-9 PMID: 25146842
37. Daghaghzadeh H, Naji F, Afshar H, Sharbafchi MR, Feizi A, Maroufi M, et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study. J Res Med Sci. 2015; 20(6): 595-601. Epub 2015/11/26. PubMed Central PMCID: PMC4621655. doi: 10.4103/1735-1995.165969 PMID: 26600836
38. Mikocka-Walus A, Hughes PA, Bampton P, Gordon A, Campaniello MA, Mavrangelos C, et al. Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn's Disease: A Pilot Randomised Placebo-Controlled Trial. J Crohns Colitis. 2016. Epub 2016/09/25.
39. Waiskopf N, Ofek K, Gilboa-Geffen A, Bekenstein U, Bahat A, Bennett ER, et al. AChE and RACK1 promote the anti-inflammatory properties of fluoxetine. J Mol Neurosci. 2014; 53(3): 306-15. Epub 2013/11/22. doi: 10.1007/s12031-013-0174-6 PMID: 24258317
40. Pandey SP, Doyen N, Mishra GC, Saha B, Chandel HS. TLR9-deficiency reduces TLR1, TLR2 and TLR3 expressions in Leishmania major-infected macrophages. Exp Parasitol. 2015; 154: 82-6. Epub 2015/04/26. doi: 10.1016/j.exppara.2015.04.005 PMID: 25911242
41. Anand PK, Tait SW, Lamkanfi M, Amer AO, Nunez G, Pages G, et al. TLR2and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation. J Biol Chem. 2011; 286(50): 42981-91. Epub 2011/10/29. PubMed Central PMCID: PMC3234870. doi: 10.1074/jbc.M111.310599 PMID: 22033934
42. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, et al. Microbial hijacking of complementtoll-like receptor crosstalk. Sci Signal. 2010; 3(109): ra11. Epub 2010/02/18. PubMed Central PMCID: PMC2824906. doi: 10.1126/scisignal.2000697 PMID: 20159852
43. Ramamoorthy S, Blakely RD. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science. 1999; 285(5428): 763-6. Epub 1999/07/31. PMID: 10427004
44. Jin J, Samuvel DJ, Zhang X, Li Y, Lu Z, Lopes-Virella MF, et al. Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells. Mol Immunol. 2011; 49(3): 423-32. Epub 2011/10/28. PubMed Central PMCID: PMC3224151. doi: 10.1016/j.molimm.2011.08.026 PMID: 22030478
45. Shin DM, Yuk JM, Lee HM, Lee SH, Son JW, Harding CV, et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol. 2010; 12 (11): 1648-65. Epub 2010/06/22. PubMed Central PMCID: PMC2970753. doi: 10.1111/j.1462-5822.2010.01497.x PMID: 20560977
46. Andreetta F, Barnes NM, Wren PB, Carboni L. p38 MAP kinase activation does not stimulate serotonin transport in rat brain: Implications for sickness behaviour mechanisms. Life Sci. 2013; 93(1): 30-7. Epub 2013/06/04. doi: 10.1016/j.lfs.2013.05.014 PMID: 23727352
47. Chang JC, Tomlinson ID, Warnement MR, Ustione A, Carneiro AM, Piston DW, et al. Single molecule analysis of serotonin transporter regulation using antagonist-conjugated quantum dots reveals restricted, p38 MAPK-dependent mobilization underlying uptake activation. J Neurosci. 2012; 32 (26): 8919-29. Epub 2012/06/30. PubMed Central PMCID: PMC3426861. doi: 10.1523/JNEUROSCI.0048-12.2012 PMID: 22745492
48. Matsumoto C, Oda T, Yokoyama S, Tominari T, Hirata M, Miyaura C, et al. Toll-like receptor 2 heterodimers, TLR2/6 and TLR2/1 induce prostaglandin E production by osteoblasts, osteoclast formation and inflammatory periodontitis. Biochem Biophys Res Commun. 2012; 428(1): 110-5. Epub 2012/10/16. doi: 10.1016/j.bbrc.2012.10.016 PMID: 23063683
49. Qiu Y, Ding Y, Zou L, Tan Z, Liu T, Fu X, et al. Divergent roles of amino acid residues inside and outside the BB loop affect human Toll-like receptor (TLR)2/2, TLR2/1 and TLR2/6 responsiveness. PLoS One. 2013; 8(4): e61508. Epub 2013/04/30. PubMed Central PMCID: PMC3634009. doi: 10.1371/journal.pone.0061508 PMID: 23626692
50. Forcen R, Latorre E, Pardo J, Alcalde AI, Murillo MD, Grasa L. Toll-like receptors 2 and 4 modulate the contractile response induced by serotonin in mouse ileum: analysis of the serotonin receptors involved. Neurogastroenterol Motil. 2015. Epub 2015/06/09.
51. Shibolet O, Podolsky DK. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am J Physiol Gastrointest Liver Physiol. 2007; 292(6): G1469-73. Epub 2007/06/08. doi: 10.1152/ajpgi.00531.2006 PMID: 17554134
52. Scheeren FA, Kuo AH, van Weele LJ, Cai S, Glykofridis I, Sikandar SS, et al. A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis. Nat Cell Biol. 2014; 16(12): 1238-48. Epub 2014/11/05. doi: 10.1038/ncb3058 PMID: 25362351